{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/glaucoma/diagnosis/ocular-hypertension-primary-open-angle-glaucoma/","result":{"pageContext":{"chapter":{"id":"f7c27cd1-50e2-5977-9f46-b1ae6e37f8c6","slug":"ocular-hypertension-primary-open-angle-glaucoma","fullItemName":"Ocular hypertension and primary open angle glaucoma","depth":2,"htmlHeader":"<!-- begin field 21ab8350-ceab-4caa-a882-08f45d0fea57 --><h2>How is ocular hypertension and primary open angle glaucoma diagnosed?</h2><!-- end field 21ab8350-ceab-4caa-a882-08f45d0fea57 -->","summary":"","htmlStringContent":"<!-- begin item c631fb0a-3c78-4a2a-b8cf-11fd67578ce0 --><!-- begin field ce4041e8-577f-4798-ad81-a95cf9188dcb --><ul><li><strong>Diagnoses of ocular hypertension and primary </strong><strong>open angle glaucoma (POAG) are usually made by an optometrist during routine eye examinations. </strong><ul><li>Typical features of POAG are: increased intraocular pressure, visual field defects, and a cupped optic disc.</li><li>An optometrist will normally refer a person with POAG to a consultant ophthalmologist for confirmation of the diagnosis.</li><li>With regard to ocular hypertension, an optometrist may refer the person to a consultant ophthalmologist depending on the degree of ocular pressure and other criteria. Some people may just require monitoring by the optometrist.</li></ul></li></ul><ul><li><strong>A GP should suspect POAG in a person with a visual field defect without other eye symptoms, or when ophthalmoscopy reveals a cupped optic disc in one or both eyes.</strong><ul><li>People are often not aware that they have a visual field defect, even when it is severe. This is because the visual fields of the eyes overlap, and so a visual field defect in one eye may be well compensated for by the other eye until that too becomes affected.</li><li>Refer the person to an optometrist for preliminary confirmation of the diagnosis, and to a consultant ophthalmologist for final confirmation of the diagnosis.</li></ul></li></ul><!-- end field ce4041e8-577f-4798-ad81-a95cf9188dcb --><!-- end item c631fb0a-3c78-4a2a-b8cf-11fd67578ce0 -->","topic":{"id":"2f2ce020-977b-56c2-bfe0-79af338099b2","topicId":"3f1d1b43-0970-4917-b518-15a04dfd4397","topicName":"Glaucoma","slug":"glaucoma","lastRevised":"Last revised in November 2020","chapters":[{"id":"b70753e1-40bf-5d64-8042-80499a3a3663","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"99932988-c7ac-5201-8a03-324771c52186","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"4665a282-8076-541c-8fdb-d884f514e73a","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"90547efd-385b-5418-95dc-840a239bb4b6","slug":"changes","fullItemName":"Changes"},{"id":"744db240-54ad-5b2b-bde1-fbf5f82dd75c","slug":"update","fullItemName":"Update"}]},{"id":"1b9b2a0b-c1eb-5850-81a4-594deb443996","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d96d012a-8a50-5197-a3bc-80be922d4ec3","slug":"goals","fullItemName":"Goals"},{"id":"ab168d63-48cb-5e39-af87-b20be5416a2b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1371aed7-3648-50af-9b62-765d61209340","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e5d9b1dc-20e2-5c90-807b-c86643d03e27","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"634d007b-489f-5899-be8c-e79e2c12d416","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"895cf400-6256-5dd3-9e84-20a916980e46","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"05123836-33c6-55ab-87b4-82c858ac280b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e281b4eb-d1e1-5e3a-ac1e-ba1ce5a60a71","slug":"definition","fullItemName":"Definition"},{"id":"1d1f8e60-4614-5dcc-a66d-9019ca4e6e03","slug":"anatomy-physiology","fullItemName":"Anatomy and physiology"},{"id":"00e7c765-c989-527f-b21f-29ad09409af8","slug":"classification","fullItemName":"Classification"},{"id":"855a9d74-8bb6-54d9-bfc9-5c385ae0f3f4","slug":"causes","fullItemName":"Causes"},{"id":"89456b4f-1b83-5bd6-ba80-018c1171090d","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"37e8081e-c003-5262-a267-bf22817b2d3d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"592dbfb6-31cc-55a6-a38e-b77abbd29565","slug":"prognosis","fullItemName":"Prognosis"},{"id":"f95b1f20-8f4d-5e8f-9e11-426b2a59246a","slug":"complications","fullItemName":"Complications"}]},{"id":"86e2bb04-52a3-5765-8605-aa439e65cf40","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c3238d06-745f-57aa-b5f9-69dc42896f15","slug":"primary-angle-closure-glaucoma","fullItemName":"Primary angle closure glaucoma"},{"id":"f7c27cd1-50e2-5977-9f46-b1ae6e37f8c6","slug":"ocular-hypertension-primary-open-angle-glaucoma","fullItemName":"Ocular hypertension and primary open angle glaucoma"},{"id":"8f240bf4-5d3c-57ba-a2f7-5e0b82983e5c","slug":"opportunistic-testing-for-glaucoma","fullItemName":"Opportunistic testing for glaucoma"}]},{"id":"c621d247-f521-559a-93ce-c62c3ab5fd2b","fullItemName":"Management","slug":"management","subChapters":[{"id":"1e08cb89-b766-5a2f-9853-4406baa8635c","slug":"acute-angle-closure-angle-closure-glaucoma","fullItemName":"Scenario: Acute angle closure and angle closure glaucoma"},{"id":"803a56e6-2082-5ccc-add9-0d7bd9f32f6a","slug":"primary-open-angle-glaucoma-intraocular-hypertension","fullItemName":"Scenario: Primary open angle glaucoma and intraocular hypertension"}]},{"id":"2d512acb-6e34-566f-8f5f-90eb0d0c8431","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"d784c3ec-391a-5275-a286-56b128e61629","slug":"topical-prostaglandin-analogues-prostamides","fullItemName":"Topical prostaglandin analogues and prostamides"},{"id":"7d644d35-69fa-5a6f-8ceb-fab24019dcee","slug":"topical-beta-blockers","fullItemName":"Topical beta-blockers"},{"id":"7a8c1c4a-8a2d-5555-828d-58b50a740f88","slug":"topical-sympathomimetics","fullItemName":"Topical sympathomimetics"},{"id":"9a1dce0a-a42d-5d80-8ded-a8444facf830","slug":"carbonic-anhydrase-inhibitors","fullItemName":"Carbonic anhydrase inhibitors"},{"id":"efeb705d-eba6-581c-93ad-0916f0aed1c4","slug":"topical-miotics","fullItemName":"Topical miotics"}]},{"id":"657fc5fb-6ac1-5cfe-8fde-6a6eaf21e17b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"14521c62-39fa-5ea2-9b3b-ba4a79d55565","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"4d0bdf94-c9fe-564d-bd78-4e6e957019c7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"4dec5995-8a6e-599f-a3ec-4401dda0f2fc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"fbee715b-cedc-51e6-91f9-00319ab7944f","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"802ad5b9-1cd1-59e9-8b22-2239d0b31c19","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4211d06e-9a65-51ea-ac4d-d35ca789f223","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"85b73253-be63-5a83-8948-152e3b5a51f7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"86e2bb04-52a3-5765-8605-aa439e65cf40","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"3be14248-3325-52b8-a035-85623ada2083","slug":"basis-for-recommendation-6c3","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 3ab5ed9a-d79c-4dc6-8aaf-0928657b5874 --><h3>Basis for recommendation</h3><!-- end field 3ab5ed9a-d79c-4dc6-8aaf-0928657b5874 -->","summary":null,"htmlStringContent":"<!-- begin item 6c33593c-1b0b-4225-b79d-93e36bd2ce87 --><!-- begin field 7b5ec219-2cce-415e-9c0a-fdf3d7f37b2b --><h4>Presentation of chronic open angle glaucoma and ocular hypertension</h4><ul><li>The information on presentation and diagnosis of primary open angle glaucoma (POAG) and ocular hypertension is based on expert opinion in the review article <em>Glaucoma </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">King, 2013</a>]<em>,</em> the textbook <em>Kanski's Clinical Ophthalmology 8th edition</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">Bowling, 2015</a>], the BMJ Best Practice guideline <em>Open-angle glaucoma</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">BMJ Best Practice, 2018</a>], and the College of Optometrists guideline <em>Glaucoma (primary open angle) (POAG)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">College of Optometrists, 2018b</a>]. The information stating that most people with glaucoma and ocular hypertension are diagnosed by optometrists is derived from two clinical guidelines, <em>Glaucoma. diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">NICE, 2017</a>] and <em>Glaucoma referral and safe discharge </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">SIGN, 2015</a>], both of which include guidance for optometrists.</li></ul><h4>Referral to a consultant ophthalmologist</h4><ul><li>The recommendation that people with POAG should be referred to a consultant ophthalmologist for confirmation of the diagnosis is a key priority for implementation in the NICE guideline <em>Glaucoma: diagnosis and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">NICE, 2017</a>] and is also reflected in guidelines from the Scottish Intercollegiate Guidelines Network <em>Glaucoma referral and safe discharge </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/glaucoma/references/\">SIGN, 2015</a>].</li></ul><!-- end field 7b5ec219-2cce-415e-9c0a-fdf3d7f37b2b --><!-- end item 6c33593c-1b0b-4225-b79d-93e36bd2ce87 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}